These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34004140)

  • 41. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
    Julander JG; Testori M; Cheminay C; Volkmann A
    Front Immunol; 2018; 9():1756. PubMed ID: 30116244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.
    Lindsey NP; Horiuchi KA; Fulton C; Panella AJ; Kosoy OI; Velez JO; Krow-Lucal ER; Fischer M; Staples JE
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30346562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus.
    Santos AP; Bertho AL; Dias DC; Santos JR; Marcovistz R
    Mem Inst Oswaldo Cruz; 2005 May; 100(3):331-7. PubMed ID: 16113878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus).
    Rodrigues SG; da Rosa AP; Galler R; Barros VL; Vieira Cde M; da Rosa JF; Azevedo Rdo S; Nunes MR; da Rosa ES; Vasconcelos PF
    Rev Soc Bras Med Trop; 2004; 37 Suppl 2():69-74. PubMed ID: 15586900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.
    Akondy RS; Monson ND; Miller JD; Edupuganti S; Teuwen D; Wu H; Quyyumi F; Garg S; Altman JD; Del Rio C; Keyserling HL; Ploss A; Rice CM; Orenstein WA; Mulligan MJ; Ahmed R
    J Immunol; 2009 Dec; 183(12):7919-30. PubMed ID: 19933869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.
    Campi-Azevedo AC; Peruhype-Magalhães V; Coelho-Dos-Reis JG; Costa-Pereira C; Yamamura AY; Lima SMB; Simões M; Campos FMF; de Castro Zacche Tonini A; Lemos EM; Brum RC; de Noronha TG; Freire MS; Maia MLS; Camacho LAB; Rios M; Chancey C; Romano A; Domingues CM; Teixeira-Carvalho A; Martins-Filho OA;
    J Immunol Methods; 2017 Sep; 448():9-20. PubMed ID: 28514646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.
    Pereira RC; Silva AN; Souza MC; Silva MV; Neves PP; Silva AA; Matos DD; Herrera MA; Yamamura AM; Freire MS; Gaspar LP; Caride E
    Vaccine; 2015 Aug; 33(35):4261-8. PubMed ID: 25862300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.
    Kwallah Ao; Inoue S; Thairu-Muigai AW; Kuttoh N; Morita K; Mwau M
    Jpn J Infect Dis; 2015; 68(3):230-4. PubMed ID: 25672346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of serological cross-reactivity between yellow fever and other flaviviruses.
    Souza NCSE; Félix AC; de Paula AV; Levi JE; Pannuti CS; Romano CM
    Int J Infect Dis; 2019 Apr; 81():4-5. PubMed ID: 30660799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
    Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
    Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans.
    Schulz AR; Mälzer JN; Domingo C; Jürchott K; Grützkau A; Babel N; Nienen M; Jelinek T; Niedrig M; Thiel A
    J Immunol; 2015 Nov; 195(10):4699-711. PubMed ID: 26459351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.
    Nascimento Silva JR; Camacho LA; Siqueira MM; Freire Mde S; Castro YP; Maia Mde L; Yamamura AM; Martins RM; Leal Mde L;
    Vaccine; 2011 Aug; 29(37):6327-34. PubMed ID: 21640779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination.
    Qi Q; Cavanagh MM; Le Saux S; NamKoong H; Kim C; Turgano E; Liu Y; Wang C; Mackey S; Swan GE; Dekker CL; Olshen RA; Boyd SD; Weyand CM; Tian L; Goronzy JJ
    Sci Transl Med; 2016 Mar; 8(332):332ra46. PubMed ID: 27030598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D.
    Querec TD; Pulendran B
    Adv Exp Med Biol; 2007; 590():43-53. PubMed ID: 17191376
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessment of immunity against Yellow Fever virus infections in northeastern Nigeria using three serological assays.
    Baba MM; Yahaya KM; Ezra EM; Adamu M; Kulloma BM; Ikusemoran M; Momoh JP; Oderinde BS
    J Med Virol; 2021 Aug; 93(8):4856-4864. PubMed ID: 33783842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparing for yellow fever vaccination.
    Devi S
    Lancet Infect Dis; 2020 Feb; 20(2):172. PubMed ID: 32006508
    [No Abstract]   [Full Text] [Related]  

  • 57. Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.
    Douam F; Ploss A
    Trends Microbiol; 2018 Nov; 26(11):913-928. PubMed ID: 29933925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response.
    Reese TA; Bi K; Kambal A; Filali-Mouhim A; Beura LK; Bürger MC; Pulendran B; Sekaly RP; Jameson SC; Masopust D; Haining WN; Virgin HW
    Cell Host Microbe; 2016 May; 19(5):713-9. PubMed ID: 27107939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
    Liang H; Lee M; Jin X
    Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.
    Co MD; Terajima M; Cruz J; Ennis FA; Rothman AL
    Virology; 2002 Feb; 293(1):151-63. PubMed ID: 11853408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.